Thks Subrie for enlightening. I do know what OR is but that bloke, Kevinchong, asked, "...agent say out OR warrant first then buy in change wa....". I was confused by that.LOL
Welcome. OR is not a warrant but it is tradeable later when listed. Even if you do not own mother share also can buy OR but have to see conversion rate. if subscribe to the OR, then warrant will come free for every OR u subscribe. Maybe he misunderstood what his agent trying to explan
Full Description: The last date and time for acceptance and payment of the Rights Issue withWarrants as well as the last date and time for excess Rights Shares applicationand payment is at 5.00 p.m. on 27 December 2016 or such later date and time asthe Board of Directors of Bioalpha may decide in its absolute discretion andannounce not less than 2 market days before the stipulated date and time.
Dispatch Date: 13/12/2016 Trading of Rights Start On: 09/12/2016 Trading of Rights End On: 19/12/2016 Stock Par Value:
Last Day and Time for: - Sale of Provisional Allotment of Right: 16/12/2016 05:00 PM - Transfer of Provisional Allotment of Right: 21/12/2016 04:00 PM - Acceptance and Payment: 27/12/2016 05:00 PM - Excess Share Application and Payment: 27/12/2016 05:00 PM
Biohlg result out. Increase in sales especially china (up14% ) but profit increase not much due expenses in hiring of new R&D staff, advertising n rebranding of retail pharmacy biz n bonus issue expenses. Also started phase 2 land clearing. Company optimistic of good result for YE 31Dec16.
Been through many right issues before and most of the time mother share surely will drop making it looks not attractive. Some will throw the share to make fund available to subscribe. What matter is the future expansion of the company.
company record history high revenue although EPS lower , it was due to share dilution after bonus share given and also higher administrative expanses expenses are needed for pharmacy chain rebranding and introducing new product in china , indonesia and local market imagine in future , those expanses can be cut down after brand is mature , the profit will be surge up suddenly indonesia factory just operate on september and all the profit will be reflect on Q4
further growth in china and indonesia market as company research , the growth of supplement in healthcare product is double digit in china market population keep on increasing , more knowledgable in improving health and hence the market of healthcare and supplement product goverment , PNB back up company itself is very optimize in future
so dont worry if the company keep on increasing in revenue and growth
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
centrio88
137 posts
Posted by centrio88 > 2016-11-22 20:53 | Report Abuse
Result is better than the previous years